What does CUSIP 929033108 represent in this 13F holders report?

CUSIP 929033108 is the security identifier for VOR - VOR BIOPHARMA INC - COMMON STOCK used to aggregate holder disclosures.

How many institutions held VOR - VOR BIOPHARMA INC - COMMON STOCK in Q4 2022?

58 institutional investors reported VOR - VOR BIOPHARMA INC - COMMON STOCK for Q4 2022. Use the holders table for investor-level position and value details.

VOR BIOPHARMA INC - COMMON STOCK (VOR)

CUSIP: 929033108

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / COMMON STOCK
Shares outstanding: 48,114,688
Total 13F shares: 60,203,525
Share change: +28,575,739
Total reported value: $400,322,462
Put/Call ratio: 5.5%
Price per share: $6.65
Number of holders: 58
Value change: +$191,043,574
Number of buys: 40
Number of sells: 10

Quarterly Holders Quick Answers

What is CUSIP 929033108?
CUSIP 929033108 identifies VOR - VOR BIOPHARMA INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 929033108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of VOR - VOR BIOPHARMA INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	23%	11,120,973	$44,261,000	—	30 Sep 2022	13F
5AM Venture Management, LLC	13F	Company	13%	6,361,723	$25,320,000	—	30 Sep 2022	13F
FMR LLC	13F	Company	6.6%	3,181,235	$12,661,000	—	30 Sep 2022	13F
Paradigm Biocapital Advisors LP	13F	Company	3.5%	1,703,645	$6,781,000	—	30 Sep 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	3%	1,465,925	$5,834,000	—	30 Sep 2022	13F
Woodline Partners LP	13F	Company	2.3%	1,111,123	$4,422,000	—	30 Sep 2022	13F
JOHNSON & JOHNSON	13F	Company	2.2%	1,074,658	$4,277,000	—	30 Sep 2022	13F
Laurion Capital Management LP	13F	Company	1.8%	857,308	$3,412,000	—	30 Sep 2022	13F
5AM Ventures VI, L.P.	3/4/5	10%+ Owner	— class O/S missing	1,766,634	$3,215,274	—	16 Nov 2021	3/4/5
VANGUARD GROUP INC	13F	Company	1.4%	657,142	$2,616,000	—	30 Sep 2022	13F
Sarissa Capital Management LP	13F	Company	1.3%	618,000	$2,460,000	—	30 Sep 2022	13F
Artal Group S.A.	13F	Company	1.1%	550,000	$2,189,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	0.91%	437,621	$1,742,000	—	30 Sep 2022	13F
OUP Management Co., LLC	13F	Company	0.78%	374,714	$1,491,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.7%	338,921	$1,349,000	—	30 Sep 2022	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.63%	302,412	$1,204,000	—	30 Sep 2022	13F
Ally Bridge Group (NY) LLC	13F	Company	0.53%	255,162	$1,016,000	—	30 Sep 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.44%	209,500	$834,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.28%	135,598	$539,000	—	30 Sep 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.27%	129,080	$514,000	—	30 Sep 2022	13F
ORBIMED ADVISORS LLC	13F	Company	0.23%	111,808	$445,000	—	30 Sep 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	79,400	$316,000	—	30 Sep 2022	13F
Ergoteles LLC	13F	Company	0.14%	65,332	$260,000	—	30 Sep 2022	13F
Bollard Group LLC	13F	Company	0.12%	55,555	$221,000	—	30 Sep 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	0.1%	46,660	$186,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	0.09%	41,213	$164,000	—	30 Sep 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.07%	32,945	$131,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.07%	31,900	$127,000	—	30 Sep 2022	13F
LMR Partners LLP	13F	Company	0.06%	26,768	$107,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.05%	23,074	$92,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	22,397	$89,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	19,062	$76,000	—	30 Sep 2022	13F
Chicago Partners Investment Group LLC	13F	Company	0.03%	14,549	$66,000	—	30 Sep 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.03%	14,834	$59,000	—	30 Sep 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.03%	14,606	$58,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	10,875	$44,000	—	30 Sep 2022	13F
BOURGEON CAPITAL MANAGEMENT LLC	13F	Company	0.02%	10,700	$43,000	—	30 Sep 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	10,412	$41,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	0.02%	7,571	$30,000	—	30 Sep 2022	13F
NISA INVESTMENT ADVISORS, LLC	13F	Company	0.01%	3,900	$19,000	—	30 Sep 2022	13F
SIMPLEX TRADING, LLC	13F	Company	0.01%	3,433	$13,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,698	$7,000	—	30 Sep 2022	13F
ROYAL BANK OF CANADA	13F	Company	0%	1,572	$6,000	—	30 Sep 2022	13F
CITIGROUP INC	13F	Company	0%	446	$2,000	—	30 Sep 2022	13F
China Universal Asset Management Co., Ltd.	13F	Company	0%	356	$1,000	—	30 Sep 2022	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	0%	250	$1,000	—	30 Sep 2022	13F
Eagle Bay Advisors LLC	13F	Company	0%	150	$1,000	—	30 Sep 2022	13F
Christopher Slapak	3/4/5	Chief Medical Officer	— class O/S missing	116,000	—	—	01 Feb 2022	3/4/5
Kush Parmar	3/4/5	Director, 10%+ Owner	— class O/S missing	16,911	—	—	14 Jun 2022	3/4/5

Institutional Holders of VOR BIOPHARMA INC - COMMON STOCK (VOR) as of Q4 2022

As of 31 Dec 2022, VOR BIOPHARMA INC - COMMON STOCK (VOR) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,203,525 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., FMR LLC, Paradigm Biocapital Advisors LP, 5AM Venture Management, LLC, Laurion Capital Management LP, Artal Group S.A., JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, and Woodline Partners LP. This page lists 58 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.